{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:40:09Z","timestamp":1749688809338,"version":"3.41.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,11]]},"DOI":"10.7759\/cureus.85803","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:03:08Z","timestamp":1749686588000},"source":"Crossref","is-referenced-by-count":0,"title":["RET (C620R) Mutation in a Hirschsprung Disease Family: A Case Report Unveiling Asymptomatic Pheochromocytoma and Unmanifested Medullary Thyroid Carcinoma"],"prefix":"10.7759","author":[{"given":"Yuko","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Suzumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kan","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706594","article-title":"Molecular genetic anatomy and risk profile of Hirschsprung\u2019s disease","volume":"380","author":"Tilghman JM","year":"2019","unstructured":"Tilghman JM, Ling AY, Turner TN, et al.. Molecular genetic anatomy and risk profile of Hirschsprung\u2019s disease. N Engl J Med. 2019, 380:1421-32. 10.1056\/NEJMoa1706594","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.31662\/jmaj.2020-0021","article-title":"Role of the RET proto-oncogene in cancer and development","volume":"3","author":"Takahashi M","year":"2020","unstructured":"Takahashi M, Kawai K, Asai N. Role of the RET proto-oncogene in cancer and development. JMA J. 2020, 3:175-81. 10.31662\/jmaj.2020-0021","journal-title":"JMA J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/367378a0","article-title":"Mutations of the RET proto-oncogene in Hirschsprung's disease","volume":"367","author":"Edery P","year":"1994","unstructured":"Edery P, Lyonnet S, Mulligan LM, et al.. Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature. 1994, 367:378-80. 10.1038\/367378a0","journal-title":"Nature"},{"key":"ref4","article-title":"Hirschsprung disease overview - retired chapter, for historical reference only","author":"Parisi MA","year":"2015","unstructured":"Parisi MA. Hirschsprung disease overview - retired chapter, for historical reference only. GeneReviews\u00ae [Internet]. Adam MP, Feldman J, Mirzaa GM, et al. (ed): University of Washington, Seattle, Seattle (WA); 2015."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2012(sup01)11","article-title":"RET haplotype, not linked to the C620R activating mutation, associated with Hirschsprung disease in a novel MEN2 family","volume":"67 Suppl 1","author":"Quedas EP","year":"2012","unstructured":"Quedas EP, Longuini VC, Sekiya T, Coutinho FL, Toledo SP, Tannuri U, Toledo RA. RET haplotype, not linked to the C620R activating mutation, associated with Hirschsprung disease in a novel MEN2 family. Clinics (Sao Paulo). 2012, 67 Suppl 1:57-61. 10.6061\/clinics\/2012(sup01)11","journal-title":"Clinics (Sao Paulo)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1272\/jnms.81.64","article-title":"An extended family with familial medullary thyroid carcinoma and Hirschsprung's disease","volume":"81","author":"Igarashi T","year":"2014","unstructured":"Igarashi T, Okamura R, Jikuzono T, Uchino S, Sugitani I, Shimizu K. An extended family with familial medullary thyroid carcinoma and Hirschsprung's disease. J Nippon Med Sch. 2014, 81:64-9. 10.1272\/jnms.81.64","journal-title":"J Nippon Med Sch"},{"key":"ref7","article-title":"Kidney malformations and Hirschsprung's disease in carriers of cysteine mutations in exon 10 of the RET proto-oncogene","volume":"73","author":"Machens A","year":"2021","unstructured":"Machens A, Lorenz K, Dralle H. Kidney malformations and Hirschsprung's disease in carriers of cysteine mutations in exon 10 of the RET proto-oncogene. Endocrine. 2021, 73:217-22. 1007\/s12020-021-02686-1","journal-title":"Endocrine"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2007.09.013","article-title":"Pheochromocytoma penetrance varies by RET mutation in MEN 2A","volume":"142","author":"Quayle FJ","year":"2007","unstructured":"Quayle FJ, Fialkowski EA, Benveniste R, Moley JF. Pheochromocytoma penetrance varies by RET mutation in MEN 2A. Surgery. 2007, 142:800-5; discussion 805.e1. 10.1016\/j.surg.2007.09.013","journal-title":"Surgery"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2006.050607","article-title":"The Ret(C620R) mutation affects renal and enteric development in a mouse model of Hirschsprung's disease","volume":"168","author":"Carniti C","year":"2006","unstructured":"Carniti C, Belluco S, Riccardi E, et al.. The Ret(C620R) mutation affects renal and enteric development in a mouse model of Hirschsprung's disease. Am J Pathol. 2006, 168:1262-75. 10.2353\/ajpath.2006.050607","journal-title":"Am J Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2009.10.080","article-title":"Familial associations in medullary thyroid carcinoma with Hirschsprung disease: the role of the RET-C620 \"Janus\" genetic variation","volume":"45","author":"Moore SW","year":"2010","unstructured":"Moore SW, Zaahl M. Familial associations in medullary thyroid carcinoma with Hirschsprung disease: the role of the RET-C620 \"Janus\" genetic variation. J Pediatr Surg. 2010, 45:393-6. 10.1016\/j.jpedsurg.2009.10.080","journal-title":"J Pediatr Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-007-9665-4","article-title":"Failure to recognize multiple endocrine neoplasia 2B: more common than we think?","volume":"15","author":"Wray CJ","year":"2008","unstructured":"Wray CJ, Rich TA, Waguespack SG, Lee JE, Perrier ND, Evans DB. Failure to recognize multiple endocrine neoplasia 2B: more common than we think?. Ann Surg Oncol. 2008, 15:293-301. 10.1245\/s10434-007-9665-4","journal-title":"Ann Surg Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/dgd.12664","article-title":"Point mutagenesis in mouse reveals contrasting pathogenetic effects between MEN2B- and Hirschsprung disease-associated missense mutations of the RET gene","volume":"62","author":"Nakatani T","year":"2020","unstructured":"Nakatani T, Iwasaki M, Yamamichi A, et al.. Point mutagenesis in mouse reveals contrasting pathogenetic effects between MEN2B- and Hirschsprung disease-associated missense mutations of the RET gene. Dev Growth Differ. 2020, 62:214-22. 10.1111\/dgd.12664","journal-title":"Dev Growth Differ"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(85)90115-1","article-title":"Activation of a novel human transforming gene, ret by DNA rearrangement","volume":"42","author":"Takahashi M","year":"1985","unstructured":"Takahashi M, Ritz J, Cooper GM. Activation of a novel human transforming gene, ret by DNA rearrangement. Cell. 1985, 42:581-8. 10.1016\/0092-8674(85)90115-1","journal-title":"Cell"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3468(00)80031-7","article-title":"Incidence of RET mutations in patients with Hirschsprung\u2019s disease","volume":"35","author":"Sancandi M","year":"2000","unstructured":"Sancandi M, Ceccherini I, Costa M, et al.. Incidence of RET mutations in patients with Hirschsprung\u2019s disease. J Pediatr Surg. 2000, 35:139-43. 10.1016\/s0022-3468(00)80031-7","journal-title":"J Pediatr Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28661","article-title":"RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma","volume":"120","author":"Krampitz GW","year":"2014","unstructured":"Krampitz GW, Norton JA. RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma. Cancer. 2014, 120:1920-31. 10.1002\/cncr.28661","journal-title":"Cancer"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells SA Jr","year":"2015","unstructured":"Wells SA Jr, Asa SL, Dralle H, et al.. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015, 25:567-610. 10.1089\/thy.2014.0335","journal-title":"Thyroid"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113268","article-title":"Results and clinical interpretation of germline RET analysis in a series of patients with medullary thyroid carcinoma: the challenge of the variants if uncertain significance","volume":"12","author":"Innella G","year":"2020","unstructured":"Innella G, Rossi C, Romagnoli M, et al.. Results and clinical interpretation of germline RET analysis in a series of patients with medullary thyroid carcinoma: the challenge of the variants if uncertain significance. Cancers (Basel). 2020, 12:3268. 10.3390\/cancers12113268","journal-title":"Cancers (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00383-023-05511-0","article-title":"Incidence of medullary thyroid carcinoma and Hirschsprung disease based on the cosmos database","volume":"39","author":"Wehrli LA","year":"2023","unstructured":"Wehrli LA, Reppucci ML, Ketzer J, et al.. Incidence of medullary thyroid carcinoma and Hirschsprung disease based on the cosmos database. Pediatr Surg Int. 2023, 39:227. 10.1007\/s00383-023-05511-0","journal-title":"Pediatr Surg Int"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-00317","article-title":"Medullary thyroid carcinoma in MEN2A: ATA moderate- or high-risk RET mutations do not predict disease aggressiveness","volume":"102","author":"Voss RK","year":"2017","unstructured":"Voss RK, Feng L, Lee JE, et al.. Medullary thyroid carcinoma in MEN2A: ATA moderate- or high-risk RET mutations do not predict disease aggressiveness. J Clin Endocrinol Metab. 2017, 102:2807-13. 10.1210\/jc.2017-00317","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/362018-ret-c620r-mutation-in-a-hirschsprung-disease-family-a-case-report-unveiling-asymptomatic-pheochromocytoma-and-unmanifested-medullary-thyroid-carcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:03:09Z","timestamp":1749686589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/362018-ret-c620r-mutation-in-a-hirschsprung-disease-family-a-case-report-unveiling-asymptomatic-pheochromocytoma-and-unmanifested-medullary-thyroid-carcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.85803","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,11]]}}}